MedTrace Logo

Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients

NCT02728739 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2018-02-06

No results posted yet for this study

Summary

The purpose of this study is to determine the prevalence of moderate-to-severe Mitral Regurgitation (MR) in acute Heart Failure (HF) patients requiring hospital admission.

Conditions

  • Acute Heart Failure
  • Mitral Regurgitation

Interventions

PROCEDURE

Transthoracic Echocardiogram (TTE) Assesment

Transthoracic Echocardiogram (TTE) will be carried out on all heart failure patients with elevated BNP level (\>30 pg/ ml) for grading of MR severity within 7 days.

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Metanoic Health Ltd.

    lead INDUSTRY

Principal Investigators

  • Aigul Baltabaeva, MBBS MD PhD · Ashford & St Peter's Hospitals NHS Foundation Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-06
Primary Completion
2017-12-29
Completion
2018-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02728739 on ClinicalTrials.gov